Table 1. Demographics and Baseline Characteristics.
| Category | Peanut Patch (n = 238) | Placebo Patch (n = 118) |
|---|---|---|
| Age, median (Q1, Q3), y | 7 (6, 9) | 7 (5, 9) |
| Sex, No. (%) | ||
| Male | 149 (62.6) | 69 (58.5) |
| Female | 89 (37.4) | 49 (41.5) |
| Race/ethnic origin, No. (%) | ||
| White | 194 (81.5) | 96 (81.4) |
| Black or African American | 1 (0.4) | 2 (1.7) |
| Asian | 19 (8) | 8 (6.8) |
| Hispanic | 2 (0.8) | 0 |
| Othera | 22 (9.2) | 12 (10.2) |
| Peanut-specific IgE, median, kUA/L | 77.9 | 101 |
| Q1, Q3 (range) | 20, 192 (0.78-1008.4) | 29.1, 232 (1.03-1104) |
| Peanut-specific IgG4, median, mg/L | 0.69 | 0.74 |
| Q1, Q3 (range) | 0.28, 1.39 (0.07-10.2) | 0.29, 1.5 (0.07-12.7) |
| Peanut protein eliciting dose, median, mg | 100 | 100 |
| Q1, Q3 (range) | 30, 300 (1-300) | 30, 300 (1-300) |
| Baseline eliciting dose, No. (%) | ||
| 1 mg | 3 (1.3) | 3 (2.5) |
| 3 mg | 10 (4.2) | 7 (5.9) |
| 10 mg | 28 (11.8) | 10 (8.5) |
| 30 mg | 24 (10.1) | 19 (16.1) |
| 100 mg | 97 (40.8) | 40 (33.9) |
| 300 mg | 76 (31.9) | 39 (33.1) |
| Medical history, No. (%) | ||
| Asthma | 117 (49.2) | 52 (44.1) |
| Eczema/atopic dermatitis | 139 (58.4) | 79 (66.9) |
| Allergic rhinitis | 132 (55.5) | 67 (56.8) |
| Allergy(ies) other than peanut | 205 (86.1) | 100 (84.7) |
Abbreviations: kUA/L, kilounits of antibody per liter; Q1, quartile 1; Q3, quartile 3.
a
Other categories: half white, half Persian; half Indian, quarter Hispanic, quarter white; quarter Filipino; 7/8 white, 1/8 Hispanic; African; American Indian; Asian and white; black and Hispanic; white and Asian (Indian); white and South Asian; white/Asian; father: Australian and mother: Iranian; German, Irish, Eastern European; half white and half black; Hispanic; Hispanic white; Indian; Mexican American; mixed; mother: Armenian and father: Korean; mother: white and father: Asian; multiracial; non-Hispanic; North African (Morocco); South Asian; South Asian/white; and participant reports both white and Asian.